Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 11.4B | 11.1B | 11.5B | 11.9B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 7.0B | 8.1B | 6.4B | 8.9B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 2.1B | 1.0B | 1.9B | 1.5B |
Tax provision | 430M | 268M | 502M | 293M |
Net income | 1.7B | 779M | 1.4B | 1.2B |
Basic EPS | 0.5 | 0.2 | 0.5 | 0.4 |
Diluted EPS | 0.5 | 0.2 | 0.4 | 0.3 |
Basic average shares | 164.2M | 164.3M | 165.2M | 166.0M |
Diluted average shares | 172.2M | 172.4M | 172.8M | 173.6M |
EBITDA | — | — | — | — |
Net income from continuing op. | 1.7B | 780M | 1.4B | 1.2B |
Minority interests | -10M | -9M | -3M | -40M |
Preferred stock dividends | — | — | — | -1M |